The FDA classified the recall as a Class I, the most serious type, according to a Feb. 23 news release.
A total of 35 complaints have been received since December 2021. Of the 35 complaints, there have been 14 reported injuries, and nine complaints involved use of a stent to manage the separated tip. No deaths have been reported at this time, according to the FDA.
